In last trading session, AEON Biopharma Inc (AMEX:AEON) saw 0.38 million shares changing hands with its beta currently measuring 0.35. Company’s recent per share price level of $0.47 trading at -$0.06 or -12.32% at ring of the bell on the day assigns it a market valuation of $4.91M. That closing price of AEON’s stock is at a discount of -133176.6% from its 52-week high price of $626.40 and is indicating a premium of 14.89% from its 52-week low price of $0.40. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.57 million shares which gives us an average trading volume of 3.37 million if we extend that period to 3-months.

For AEON Biopharma Inc (AEON), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.

AEON Biopharma Inc (AMEX:AEON) trade information

Upright in the red during last session for losing -12.32%, in the last five days AEON remained trading in the red while hitting it’s week-highest on Tuesday, 04/01/25 when the stock touched $0.47 price level, adding 22.95% to its value on the day. AEON Biopharma Inc’s shares saw a change of -98.80% in year-to-date performance and have moved -21.42% in past 5-day. AEON Biopharma Inc (AMEX:AEON) showed a performance of -34.37% in past 30-days. Number of shares sold short was 0.17 million shares which calculate 0.02 days to cover the short interests.

AEON Biopharma Inc (AMEX:AEON)’s Major holders

Insiders are in possession of 9.73% of company’s total shares while institution are holding 3.44 percent of that, with stock having share float percentage of 3.81%. Investors also watch the number of corporate investors in a company very closely, which is 3.44% institutions for AEON Biopharma Inc that are currently holding shares of the company.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 5.76 shares of worth $2685.0 or 0.05% of the total outstanding shares. The later fund manager was in possession of 4.46 shares on Dec 31, 2024 , making its stake of worth around $2076.0 in the company or a holder of 0.04% of company’s stock.